{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:47:57Z","timestamp":1792511277173,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019540","name":"Science Fund for Distinguished Young Scholars of Zhejiang Province","doi-asserted-by":"publisher","award":["LR22H260001"],"award-info":[{"award-number":["LR22H260001"]}],"id":[{"id":"10.13039\/501100019540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000779","name":"University of London","doi-asserted-by":"publisher","award":["CL-2020-16-001"],"award-info":[{"award-number":["CL-2020-16-001"]}],"id":[{"id":"10.13039\/501100000779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204019"],"award-info":[{"award-number":["82204019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20210351"],"award-info":[{"award-number":["20210351"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-00977"],"award-info":[{"award-number":["2019-00977"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C31250\/A22804"],"award-info":[{"award-number":["C31250\/A22804"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ebiom.2023.104488","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T16:45:08Z","timestamp":1677257108000},"page":"104488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5055-5627","authenticated-orcid":false,"given":"Shuai","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengzhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7832-2518","authenticated-orcid":false,"given":"Haochao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Spiliopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evropi","family":"Theodoratou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-0341","authenticated-orcid":false,"given":"Susanna C.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104488_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2021-eular.1002","article-title":"POS1042 efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, compared with placebo and apremilast in moderate to severe plaque psoriasis: results from the phase 3 poetyk PSO-1 study","volume":"80","author":"Armstrong","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104488_bib2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1806382","article-title":"Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis","volume":"379","author":"Papp","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104488_bib3","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1053\/j.gastro.2020.01.047","article-title":"Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn's disease","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104488_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus placebo or adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.ebiom.2023.104488_bib5","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa1708337","article-title":"Effects of sotagliflozin added to insulin in patients with type 1 diabetes","volume":"377","author":"Garg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104488_bib6","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/ecco-jcc\/jjaa049","article-title":"Development of gut-selective pan-janus kinase inhibitor TD-1473 for ulcerative colitis: a translational medicine programme","volume":"14","author":"Sandborn","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"issue":"Supplement_1","key":"10.1016\/j.ebiom.2023.104488_bib7","doi-asserted-by":"crossref","first-page":"i091","DOI":"10.1093\/ecco-jcc\/jjab232.081","article-title":"DOP42 Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with moderately-to-severely active Ulcerative Colitis: 12-week results from the Phase 2 LATTICE-UC study","volume":"16","author":"Danese","year":"2022","journal-title":"J\u00a0Crohn's Colitis"},{"key":"10.1016\/j.ebiom.2023.104488_bib8","series-title":"FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions","author":"USFaD Administration","year":"2021"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104488_bib9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/ijc.34180","article-title":"Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk","volume":"151","author":"Yarmolinsky","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ebiom.2023.104488_bib10","series-title":"Mendelian Randomization: Methods for Using Genetic Variants in Causal Estimation","author":"Burgess","year":"2015"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104488_bib11","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1038\/s41467-018-06540-3","article-title":"Phenome-wide association studies across large population cohorts support drug target validation","volume":"9","author":"Diogo","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104488_bib12","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data","volume":"31","author":"Denny","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104488_bib13","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/annrheumdis-2017-212534","article-title":"MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank","volume":"77","author":"Li","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104488_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002937","article-title":"Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: a phenome-wide mendelian randomization study","volume":"16","author":"Li","year":"2019","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104488_bib15","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ije\/dyac036","article-title":"Genetically predicted sex hormone levels and health outcomes: phenome-wide Mendelian randomization investigation","volume":"51","author":"Yuan","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"7944","key":"10.1016\/j.ebiom.2023.104488_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104488_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng.3506","article-title":"Integrative approaches for large-scale transcriptome-wide association studies","volume":"48","author":"Gusev","year":"2016","journal-title":"Nat Genet"},{"issue":"7675","key":"10.1016\/j.ebiom.2023.104488_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Battle","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104488_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat Genet"},{"issue":"7488","key":"10.1016\/j.ebiom.2023.104488_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis\u00a0contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104488_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104488_bib22","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104488_bib23","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/s41467-019-09773-y","article-title":"A\u00a0systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis","volume":"10","author":"Consortium","year":"2019","journal-title":"Nat Commun"},{"issue":"7863","key":"10.1016\/j.ebiom.2023.104488_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics","volume":"594","author":"Chiou","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104488_bib25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","article-title":"Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci","volume":"50","author":"Schumacher","year":"2018","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104488_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","article-title":"Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses","volume":"52","author":"Zhang","year":"2020","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104488_bib27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104488_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104488_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009440","article-title":"A\u00a0more accurate method for colocalisation analysis allowing for multiple causal variants","volume":"17","author":"Wallace","year":"2021","journal-title":"PLoS Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104488_bib30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/rssb.12388","article-title":"A\u00a0simple new approach to variable selection in regression, with application to genetic fine mapping","volume":"82","author":"Wang","year":"2020","journal-title":"J\u00a0Roy Stat Soc B"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104488_bib31","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","article-title":"The allelic landscape of human blood cell trait variation and links to common complex disease","volume":"167","author":"Astle","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2023.104488_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104488_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ebiom.2023.104488_bib34","series-title":"MAGIC (the meta-analyses of glucose and insulin-related traits consortium)","year":"2020"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104488_bib35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"issue":"21","key":"10.1016\/j.ebiom.2023.104488_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.21037\/atm.2016.11.11","article-title":"Causal mediation analysis in the context of clinical research","volume":"4","author":"Zhang","year":"2016","journal-title":"Ann Transl Med"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104488_bib37","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1056\/NEJMe1901565","article-title":"Human genetics and drug development","volume":"380","author":"Holmes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104488_bib38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"Beecham","year":"2013","journal-title":"Nat Genet"},{"issue":"7422","key":"10.1016\/j.ebiom.2023.104488_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104488_bib40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jcph.1046","article-title":"The safety, tolerability, pharmacokinetics, and pharmacodynamics of a TYK2\/JAK1 inhibitor (PF-06700841) in healthy subjects and patients with plaque psoriasis","volume":"58","author":"Banfield","year":"2018","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104488_bib41","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.jid.2020.03.962","article-title":"TYK2\/JAK1 inhibitor PF-06700841 in patients with plaque psoriasis: phase IIa, randomized, double-blind, placebo-controlled trial","volume":"140","author":"Forman","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104488_bib42","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/S2665-9913(20)30397-0","article-title":"Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study","volume":"3","author":"Tehlirian","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104488_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s13555-021-00649-y","article-title":"Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial","volume":"12","author":"Tha\u00e7i","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104488_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.immuni.2006.10.007","article-title":"Human tyk2 kinase deficiency: another primary immunodeficiency syndrome","volume":"25","author":"Watford","year":"2006","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104488_bib45","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","article-title":"Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity","volume":"25","author":"Minegishi","year":"2006","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104488_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O'Shea","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104488_bib47","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/ijc.34180","article-title":"Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk","volume":"151","author":"Yarmolinsky","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ebiom.2023.104488_bib48","article-title":"Efficacy and safety of brepocitinib (tyrosine kinase 2\/janus kinase 1 inhibitor) for the treatment of active psoriatic arthritis: results from a phase 2b randomized controlled trial","author":"Mease","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104488_bib49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2021-221664","article-title":"Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis","volume":"81","author":"Mease","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104488_bib50","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41418-020-00621-x","article-title":"TYK2 licenses non-canonical inflammasome activation during endotoxemia","volume":"28","author":"Poelzl","year":"2021","journal-title":"Cell Death Differ"},{"issue":"18","key":"10.1016\/j.ebiom.2023.104488_bib51","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1002\/cam4.3345","article-title":"Insulin-like growth factor-1 and site-specific cancers: a Mendelian randomization study","volume":"9","author":"Larsson","year":"2020","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104488_bib52","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1210\/clinem\/dgaa963","article-title":"Insulin-like growth factor-1, bone mineral density, and fracture: a mendelian randomization study","volume":"106","author":"Yuan","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6569","key":"10.1016\/j.ebiom.2023.104488_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj1541","article-title":"Mapping the proteo-genomic convergence of human diseases","volume":"374","author":"Pietzner","year":"2021","journal-title":"Science"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:23:37Z","timestamp":1762457017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":53,"alternative-id":["S2352396423000531"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104488","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104488"}}